Login to Your Account

Recent start-up Cour lands former Pfizer R&D chief as chairman

By Michael Fitzhugh
Staff Writer

Wednesday, May 21, 2014
Cour Pharmaceutical Development Co. Inc., a small company developing nanotechnology-based immunotherapies for acute inflammation and autoimmune disease, has appointed Pfizer R&D veteran Catherine Mackey as chairman of its board. Founded in 2012, the Elmhurst, Ill.-based Northwestern University spinout is still preclinical.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription